Nitrous oxide

Description

No description information is available.

Uses and Indications

Nitrous Oxide USP is indicated for use in clinical settings where its administration is deemed appropriate by a licensed practitioner. This drug should only be administered by or under the supervision of a healthcare professional who possesses expertise in the use and administration of Nitrous Oxide USP. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the necessity for administration by qualified personnel, ensuring that all safety protocols and guidelines are strictly followed to mitigate potential risks associated with its use. There are no reported teratogenic or nonteratogenic effects associated with Nitrous Oxide USP.

Dosage and Administration

Administration of Nitrous Oxide USP is intended solely for use by or under the supervision of a licensed practitioner experienced in its use and administration, as it may pose hazards or contraindications.

The route of administration is via respiratory inhalation. The active ingredient is nitrous oxide, provided at a strength of 990 mL in 1 L. Practitioners should ensure that appropriate safety measures are in place during administration to mitigate any potential risks associated with the use of nitrous oxide.

Contraindications

Administration of Nitrous Oxide USP is contraindicated in situations where safety precautions have not been fully understood and implemented. Due to the potential hazards associated with its use, it is imperative to avoid breathing the gas directly. Additionally, the use and storage of Nitrous Oxide USP should be restricted to outdoor environments or well-ventilated areas to mitigate risks. Spills must be avoided, and it is crucial not to walk or roll equipment over any spills to prevent accidents.

Warnings and Precautions

Healthcare professionals are advised to adhere to the following warnings and precautions to ensure the safe use of the product.

Warnings

It is imperative to avoid inhalation of the gas. The product should only be used and stored outdoors or in a well-ventilated area to minimize exposure risks. Personal protective equipment is essential; users must wear cold insulating gloves, a face shield, and eye protection to prevent injury.

In the event of a fire, efforts should be made to stop the leak if it is safe to do so. A backflow preventative device must be utilized in the piping to prevent contamination. Equipment used with this product must be constructed of compatible materials and rated for cylinder pressure. Additionally, only equipment that has been cleaned for oxygen service should be employed.

Spills must be avoided, and personnel should not walk or roll equipment over any spills that may occur. It is crucial to close the valve after each use and when the cylinder is empty. Prior to use, the Safety Data Sheet (SDS) must be read and followed to ensure comprehensive understanding of the hazards and safety measures associated with the product.

General Precautions

In the event of inhalation, the affected individual should be removed to fresh air and kept comfortable for breathing. If the person feels unwell, it is essential to contact a poison center or a physician for further assistance.

For skin exposure, any frosted areas should be thawed using lukewarm water, and the affected area should not be rubbed. Immediate medical advice or attention should be sought in such cases.

Emergency Medical Help Instructions

If any adverse effects are experienced, particularly if the individual feels unwell, it is critical to call a poison center or a physician for emergency medical help.

Stop Taking and Call Your Doctor Instructions

Immediate medical advice or attention should be obtained if there is any skin exposure to the product.

Side Effects

Patients receiving nitrous oxide may experience a range of adverse reactions. Common adverse reactions include dizziness, nausea, vomiting, and headache. These effects are generally mild and may resolve without intervention.

Serious adverse reactions associated with nitrous oxide use include hypoxia, respiratory depression, cardiac arrest, and neurological effects such as peripheral neuropathy. A boxed warning highlights the potential for serious adverse effects, particularly in patients with pre-existing respiratory conditions, emphasizing the need for caution in this population.

Additionally, prolonged exposure to nitrous oxide may lead to vitamin B12 deficiency. Rare cases of severe allergic reactions have also been reported in patients, necessitating monitoring for any signs of hypersensitivity.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

There is no specific pediatric use information available for this medication, including recommended ages, dosing differences, safety concerns, or special precautions for children. Healthcare professionals should exercise caution when considering the use of this medication in pediatric patients due to the absence of relevant data.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Administration of Nitrous Oxide USP may be hazardous or contraindicated in pregnancy. While the specific risks to the fetus are not detailed in the available data, caution is advised when considering the use of this agent in pregnant patients. Healthcare professionals should carefully evaluate the potential benefits and risks before administering Nitrous Oxide to women of childbearing potential.

Lactation

There are no specific statements or considerations regarding lactation or nursing mothers in the provided text. Therefore, the effects on breastfed infants and the excretion of the drug in breast milk remain undetermined. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the insert for Nitrous Oxide. Therefore, healthcare professionals should exercise caution when administering this agent to patients with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, remain observant for potential overdose symptoms, and implement appropriate management strategies as needed.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: drowsiness, dizziness, and a potential risk of rapid suffocation due to oxygen displacement. These events have been documented in the context of postmarketing surveillance and are presented without speculation regarding causality.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrous Oxide USP may pose hazards or be contraindicated in certain situations. It is essential that this substance is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. The practitioner should be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be made aware of the potential dangers associated with Nitrous Oxide USP, including its ability to cause or intensify fire, as it is classified as an oxidizer. Additionally, the gas is stored in a refrigerated state, which may lead to cryogenic burns or injuries if not handled properly. Patients should be informed that the use of Nitrous Oxide may result in drowsiness or dizziness and that it can displace oxygen, leading to rapid suffocation.

It is crucial for patients to understand the importance of reading and comprehending all safety precautions before handling Nitrous Oxide. They should be instructed to keep and store the gas away from clothing and other combustible materials, ensuring that valves and fittings remain free from grease and oil. Patients should avoid breathing in the gas and are advised to use and store it only outdoors or in well-ventilated areas. The use of cold insulating gloves, face shields, and eye protection is recommended during handling.

In the event of a fire, patients should be instructed to stop the leak if it is safe to do so. They should also be informed about the necessity of using a backflow preventative device in the piping and that only equipment made from compatible materials and rated for cylinder pressure should be utilized. Equipment must be cleaned for oxygen service, and patients should avoid spills, refraining from walking or rolling equipment over any spills that may occur. It is important to close the valve after each use and when the cylinder is empty.

Patients should be encouraged to read and follow the Safety Data Sheet (SDS) prior to use. In case of an emergency, if Nitrous Oxide is inhaled, patients should be removed to fresh air and kept comfortable for breathing. They should seek medical attention by calling a poison center or a physician if they feel unwell. If the gas comes into contact with skin, patients should thaw any frosted areas with lukewarm water without rubbing the affected area and should seek immediate medical advice or attention.

Storage and Handling

The product is supplied in containers that must always be kept in an upright position. It is essential to store the product away from clothing and other combustible materials to ensure safety. Valves and fittings should be maintained free from grease and oil to prevent any potential hazards.

For optimal safety, the product should be used and stored exclusively outdoors or in a well-ventilated area. Personnel handling the product are advised to wear cold insulating gloves, a face shield, and eye protection to minimize exposure risks. It is crucial to close the valve after each use and when the container is empty to maintain safety and integrity.

Additional Clinical Information

No further data are available.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide as submitted by Roberts Oxygen Company, Inc.. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)